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Neural stem cells have been adopted tomodel awide
range of neuropsychiatric conditions in vitro. How-
ever, how well such models correspond to in vivo
brain has not been evaluated in an unbiased,
comprehensive manner. We used transcriptomic
analyses to compare in vitro systems to developing
human fetal brain and observed strong conservation
of in vivo gene expression and network architecture
in differentiating primary human neural progenitor
cells (phNPCs). Conserved modules are enriched in
genes associated with ASD, supporting the utility of
phNPCs for studying neuropsychiatric disease. We
also developed and validated a machine learning
approach called CoNTExT that identifies the devel-
opmental maturity and regional identity of in vitro
models. We observed strong differences between
in vitro models, including hiPSC-derived neural pro-
genitors from multiple laboratories. This work pro-
vides a systems biology framework for evaluating
in vitro systems and supports their value in studying
the molecular mechanisms of human neurodevelop-
mental disease.
INTRODUCTION
Human neural stem cells are poised to revolutionize our ability to
make mechanistic inferences, bridging the gap between tradi-
tional model systems and human biology (Dolmetsch and
Geschwind, 2011; Merkle and Eggan, 2013). Ideally, such a plat-
form should maximize translational potential by recapitulating
in vivo brain development and function as much as possible.
Human embryonic stem (hES), induced pluripotent stem (hiPS),and primary human neural progenitor (phNPC) cells all have
the ability to differentiate into functional neurons (Espuny-
Camacho et al., 2013; Hansen et al., 2011; Palmer et al., 2001;
Sandoe and Eggan, 2013). In each of these systems, disease-
related processes can be modeled and studied by either gener-
ating hiPSCs from patients with known mutations or introducing
genetic modifications into control neural stem cell lines (An et al.,
2012; Brennand et al., 2011; Israel et al., 2012; Marchetto et al.,
2010; Pasxca et al., 2011; Rosen et al., 2011; Ryan et al., 2013;
Soldner et al., 2011). Despite many options, there is neither a
clear consensus as to which system or culture conditions are
better suited to model aspects of neurodevelopment and dis-
ease nor a rubric for answering this question. The following
have not been demonstrated using a rigorous genome-wide
statistical framework: (1) how well in vitro models match in vivo
development, (2) what level of developmental maturity is
achieved after differentiation, (3) what neuroanatomical identity
is modeled, (4) what specific neurodevelopmental processes
and molecular mechanisms are preserved, and (5) what specific
aspects remain to be better modeled in vitro, providing a guide
for future work optimizing in vitro systems.
Recent large-scale efforts to measure the transcriptome from
postmortem human brain provide an unbiased in vivo standard
to which in vitro systems can be compared. These data sets
measure gene expression at time points from embryonic to
late adulthood and across several cortical and subcortical
regions (Kang et al., 2011). In addition, gene expression inmicro-
dissected cortical laminae has beenmeasured at mid to late fetal
time periods (Miller et al., 2014), providing data sets with
increased spatial resolution within a restricted developmental
window.
Here, we develop and demonstrate genome-wide methods to
quantify the similarity between in vitro neural stem cell models
and brain development in vivo and apply them to a newly gener-
ated set of phNPC lines. We demonstrate remarkable preserva-
tion of neurodevelopmental processes spanning embryonic to
fetal corticogenesis in phNPCs in vitro. But, even after monthsNeuron 83, 69–86, July 2, 2014 ª2014 Elsevier Inc. 69
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In Vitro Stem Cells Model In Vivo Developmentin a dish, neither phNPCs nor hiPSC-derived neurons mature
beyond fetal stages. We further uncover gene expression
networks driving these processes, show their preservation
in vitro, and reveal they are enriched in autism spectrum disor-
ders (ASDs) risk genes. Finally, we expand this analysis to
hiPSC- and hES-based neural stem cell models and find striking
differences in overlap to in vivo development and preservation of
network architecture. We have implemented this framework into
a user-friendly website (http://context.semel.ucla.edu/) as a
resource for the community.
RESULTS
phNPCs Express Telencephalic Markers and Undergo
Stereotypical Neuronal Morphogenesis upon
Differentiation
We generated phNPC lines from 15–18 postconception week
(PCW) human fetal brains by a neurosphere isolation method
(Konopka et al., 2012; Palmer et al., 2001; Rosen et al., 2011;
Wexler et al., 2011) (Figure 1A; Experimental Procedures avail-
able online). All lines were genotyped to determine sex and to
exclude samples with aneuploidy. Immunostaining of undifferen-
tiated phNPCs was consistent with standard methods used to
define dorsal telencephalic progenitors/radial glia of human
cortex (Hansen et al., 2010) (Figures 1B and 1C). During differen-
tiation, the typical progression of decrease in mitotic and neural
stem cell markers (Ki-67 and NES) with concomitant increase in
neuronal markers (Tuj1, DCX, and MAP2) during cortical matura-
tion was observed (Figures 1D and 1E; data not shown). We also
detected cells expressing TBR2, a marker of intermediate pro-
genitor cells (Englund et al., 2005; Hansen et al., 2010), all of
which costained with PAX6, consistent with the immunocyto-
chemical profile of the ISVZ (Betizeau et al., 2013; Fietz et al.,
2010) (data not shown). The in vitro expression profile of genes
marking laminar potential and fate across differentiation was
also consistent with sequential generation of lower and upper
layer projection neurons during corticogenesis (Arlotta et al.,
2005; McEvilly et al., 2002) (Figures S1A–S1C). In addition,
phNPCs generate neurons with stereotypical morphologies
similar to what is observed in vivo, first forming bipolar migrating
cells, followed by axonogenesis and increases in dendritic arbor-
ization (Figures 1F and 1G).
Few commonly used literature-basedmarkers are specific to a
single region (Figure S2A). For instance, PAX6 is widely used as a
dorsal telencephalic marker (Espuny-Camacho et al., 2013;
Pasxca et al., 2011), as it largely separates the dorsal palliumFigure 1. phNPCs Express Canonical Telencephalic Markers and Unde
(A) Isolation, culture, and differentiation of phNPCs from human fetal cortex.
(B and C) Isolated phNPCs express dorsal telencephalic and radial glia markers
indicated antibodies and the DNA-binding dye 40,6-diamidino-2-phenylindole (D
cephalic and radial glia (PAX6, SOX2; 97%, n = 395 cells), and mitotic (Ki-67; 36
(D and E) Differentiation of phNPCs into MAP2+ neurons with concomitant decrea
cells; Ki-67, n = 1,693 cells). Box plot whiskers encompass all points within 1.5 3
(F) phNPCswere infectedwith a low titer of turboRFP-expressing lentivirus (pTRIP
at 2, 5, and 12 weeks postdifferentiation. Axo-dendritic polarization and increa
arrowheads indicate dendrites and axons, respectively.
(G) Quantification of dendrite morphogenesis in MAP2+ neurons treated as in (F)
time point in five lines from three donors; mean ±SEM displayed in barplot). Scafrom ventral pallium, but it is also strongly expressed in other
brain regions, including the developing diencephalon and hind-
brain (Manuel and Price, 2005) (Figure S2A). To overcome this
limitation, we generated a list of genes enriched in different brain
regions based on transcriptomic data from human brain (Kang
et al., 2011) (Supplemental Experimental Procedures) and used
these gene sets as an initial standard. Cortical regional markers
were highly expressed in all phNPC lines, while expression of
markers of other brain regions was much lower (Figure 2).
Further, expression of the majority of literature-based markers
was also very similar between in vivo cortex and phNPCs (Fig-
ures S2B and S2C), further validating the cortical identity of
phNPC cultures using an unbiased approach.
Mapping In Vitro Differentiation of phNPCs to In Vivo
Cortical Development
We next developed an unbiased genome-wide transition map-
ping (TMAP) approach to assess the extent of overlap between
in vivo cortical development and in vitro differentiation. TMAP
consists of serialized differential expression analysis between
any two in vivo developmental periods defined from a spatiotem-
poral transcriptomic atlas (Kang et al., 2011) and any two in vitro
differentiation time points, followed by quantification of overlap
using the rank-rank hypergeometric overlap test (Plaisier et al.,
2010) for each combination of time periods. This method has
the advantage of allowing for a threshold-free (1) identification
of which in vivo developmental transition best overlaps with
differentiating phNPCs and (2) statistical assessment of the
extent of overlap. This technique generates a map of the overlap
between any two systems across development.
We applied TMAP, comparing a signed, p value-ranked list of
differentially expressed (DE) genes over 12 weeks of differentia-
tion in vitro to genes DE between the listed developmental
periods fromhuman cortex (Figure 3A) and observed strong over-
lapbetweenphNPCand cortical developmental periods up to late
mid-fetal periods (maxlog10(p value) > 460). The strong match-
ing observed in transitions fromperiod 1 or 2 is consistentwith the
differentiation of the progenitor-enriched week 1 postdifferentia-
tion (PD) time point (Figure 1C), since the in vivo data set only
includes cortical germinal zones in periods 1 and 2 (Kang et al.,
2011). Genes coordinately upregulated in vitro and in vivo driving
the overlap are related to processes of normal neuronal differen-
tiation, whereas codownregulated genes are related to mitosis,
cell-cycle arrest, andcarbohydrate utilization (Figures3Band3C).
Examples of key candidate genes that have preserved rank-
ings show remarkably similar trajectories of gene expressionrgo Stereotypical Neuronal Morphogenesis
. Undifferentiated phNPCs were subjected to immunocytochemistry with the
API). Telencephalic (FOXG1, 100%, ASCL1, 19%; n = 368 cells), dorsal telen-
%, n = 395 cells) markers are expressed.
se in neural progenitors (Nestin, Ki-67) across the indicated time points (n = 794
(interquartile range).
Z) and subjected to immunocytochemistry withMAP2 and turboRFP antibodies
sed dendritic complexity is observed over development in vitro. Arrows and
shows robust dendrite growth and branching over differentiation (n = 23 cells/
le bar equal 50 mm for all panels.
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Figure 2. Expression of Transcriptomically Defined Regional Markers In Vitro and In Vivo
Expression levels of 5 to 20 marker genes enriched in each indicated brain region during late mid-fetal in vivo development (Period 6) along with 12 week PD
phNPCs are shown. Genes are shown on the x axis with colors to indicate the region for which the gene is a marker. The y axis indicates the in vivo dissected
region or in vitro cell line, specified by donor identification number and region identification number. Relative expression is indicated by color within the heat map
and normalized for each gene from 0 to 1. Cortex: OFC, DFC, VFC,MFC,M1C, S1C, IPC, A1C, STC, ITC, and V1C; Hippocampus: HIP; Amygdala; AMY; Striatum:
STR; Medial Dorsal Nucleus of the Thalamus: MD; and Cerebellar Cortex: CBC.
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In Vitro Stem Cells Model In Vivo Developmentwhen compared to in vivo development up to period 6 (Fig-
ure 3C). Mapping the in vitro transitions between periods 1 to
4, periods 4 to 8, and periods 8 to 12 weeks PD to in vivo devel-
opmental periods allows for visualization of the progressive
maturation of phNPCs cultures (Figure S3B). It is evident that
later transitions in differentiation correspond to later periods of
human development.
Next, we sought to apply this same TMAP tool to transcrip-
tomes derived from laser capture microdissection of cortical
laminae from postmortem human fetal brain (15–21 PCW) (Miller
et al., 2014), permitting a direct assessment of in vivo matching
between cortical neural progenitors and their postmitotic deriva-
tives. The transition between 1 and 12weeks PD in differentiating
phNPCs has strongest correspondence to the transition
between the ventricular zone or subventricular zone to subplate
and inner cortical plate (Figure 3D). As expected, this overlap is
largely driven by synaptic genes coordinately upregulated and
cell-cycle genes codownregulated during the transition between
subventricular zone and inner cortical plate in vivo and the tran-
sition between 1 and 12 week PD in vitro (Figure 3E).
Individual In Vitro Sample Prediction of Regional Identity
and Developmental Period
The above analyses perform group-based determination of
developmental period. We sought to develop an approach that
would allow determination of these features in individual sam-
ples, thus precluding the need to pool samples into groups or
to compare between specific stages or transitions. We devel-
oped a multilabel (developmental period and regional identity),
multiclass (periods: 1–15; regions: cortex, hippocampus, amyg-
dala, thalamus, striatum, and cerebellum) machine learning72 Neuron 83, 69–86, July 2, 2014 ª2014 Elsevier Inc.framework (Tsoumakas and Katakis, 2007), named Classifica-
tion ofNeuroanatomical and Temporal Expression via Transcrip-
tomics (CoNTExT), for this purpose. We trained the algorithm
on a spatiotemporal transcriptome atlas of the human brain
(Kang et al., 2011) (Figure 4A). After feature selection and par-
ameter optimization (Experimental Procedures), cross-validation
accuracy in the training data set was high (10-fold cross-
validation with 90% split percentage; exact accuracy for devel-
opmental period: 99.6%; accuracy for regional identification:
96.9%).
We then applied this recognition algorithm to four other data
sets of transcriptional profiling from postmortem human brain
to provide independent validation (Hernandez et al., 2012; Israel
et al., 2012; Johnson et al., 2009; Liu et al., 2012), attaining high
levels of accuracy in each of these new data sets, despite
differences in microarray platforms, processing of samples,
and laboratories (Figures 4A, 4B, and S4A–S4C). Importantly,
in the same platform as the in vitro phNPCs data (Illumina
HT-12 Beadchip), the algorithm was able to correctly classify
both fetal (Figure S4B) (Israel et al., 2012) and adult brain (911
samples; Figure S4C) (Hernandez et al., 2012). Overall, CoNTExT
is accurate at differentiating distinct in vivo developmental
epochs from each other (e.g., between early, mid, and late fetal;
fetal versus newborn; childhood versus adolescence; and child-
hood versus adulthood).
We next applied CoNTExT to phNPC cultures to predict the
developmental period and regional identity of each phNPC
sample (see Supplemental Experimental Procedures). A pro-
gressive maturation of the culture can be seen across multiple
differentiation weeks (Figure 4C). Similar to results from TMAP,
but now for each single sample individually, we predict that these
Neuron
In Vitro Stem Cells Model In Vivo Developmentcultures match most closely to embryonic development at
1 week PD and early to late mid-fetal development at 12 weeks
PD. As in TMAP, the strong prediction of embryonic develop-
ment at 1 week PD is likely due to the in vivo data set containing
proliferative laminae of the cortex for these time periods only and
the culture containing predominantly proliferative cells. In addi-
tion, regional prediction is strongly cortical, consistent with
high expression of cortical markers in the developing phNPCs
(Figure 1 and Figure 2).
Network Analysis Identifies Key Preserved
Neurodevelopmental Processes in Differentiating
phNPCs
Although TMAP and CoNTExT provide a cohesive framework to
determine neuroanatomical region and developmental maturity,
these methods are not tailored to characterize the preservation
of specific cellular or biochemical processes. To identify
which specific neurodevelopmental processes were preserved
in vitro, we employed weighted gene coexpression network
analysis (WGCNA). WGCNA identifies modules of coexpressed
genes that correspond to shared function—for example, organ-
elles, cell types, or biological processes. (Hawrylycz et al., 2012;
Johnson et al., 2009; Kang et al., 2011; Miller et al., 2014; Old-
ham et al., 2008; Parikshak et al., 2013; Voineagu et al., 2011).
We constructed a network based on coexpression of genes in
developing human cortex (Periods 1–8) (Kang et al., 2011) and
assessed preservation of the network (Langfelder et al., 2011)
(Experimental Procedures) in an independent in vivo data set
of developing human cortex (Colantuoni et al., 2011) to identify
the most robust and generalizable modules, identifying 28
well-preserved modules (Preservation Z score R4) (Table 1;
Figure S5A). This network, defined in developing fetal cortex,
represents a rubric for comparing in vitro development to in vivo
development and identifying shared processes and mecha-
nisms. We found that the majority of our high-confidence mod-
ules were strongly correlated with developmental period, but
not as strongly with areal identity or hemisphere, suggesting
modules are largely reflective of processes related to differenti-
ation and maturation (Figure S5B).
We next assessed shared gene function within the module by
enrichment of Gene Ontology (GO) terms, KEGG pathway anal-
ysis, and overrepresentation of genes in manually curated lists
comprising key neurodevelopmental processes, brain cell
populations, and their subcellular compartments (Figures 5B
and S5D; Table 1). We identified modules related to major histo-
genetic and cellular processes driving cortical development,
including exit from cell cycle (magenta, red, and grey60 mod-
ules), neurogenesis and differentiation (pink and magenta mod-
ules), axon growth and guidance and neuronal migration (purple,
salmon, and greenmodules), dendrite growth (salmon and green
modules), and synaptogenesis (green, salmon, lightgreen, cyan,
paleturquoise, and yellow modules; Figures 5A and 5B; Table 1).
The trajectory of gene expression over the developmental period
(e.g., module eigengene), GO terms, and key hub genes are illus-
trated for a subset of these modules in Figure 5B. For instance,
modules related to neural progenitor proliferation (magenta
and pink) have eigengenes that decrease over time and contain
mitotic checkpoint kinases as hubs (BUB1 and BUB1B;magenta) (Taylor and McKeon, 1997), as well as known markers
of radial glia (PAX6, VIM, and NES; magenta); intermediate pro-
genitors (EOMES; magenta); members of the Notch/delta
signaling pathway NOTCH1 (magenta), NOTCH2, and HES1
(pink) (Kageyama et al., 2008); and members of the SHH
signaling pathway (SMO, GLI2, and GLI3; magenta) (Sousa
and Fishell, 2010). Interestingly, the pink module is also enriched
in genes related to gliogenesis and astrocytes, including SOX8
and SOX9 (Kang et al., 2012; Stolt et al., 2003), and its eigengene
is upregulated in late fetal development, consistent with the
timing of gliogenesis in human cortex (Figures 5B and S5D)
(Kriegstein and Alvarez-Buylla, 2009; Rakic, 2003).
A set of modules with trajectories of increasing expression
over development mark different phases of neurogenesis. The
purple module related to neuronal migration and axon guidance
displays elevated expression during Periods 3–6, faithfully reca-
pitulating the time period of these processes in vivo (Figure 5A),
and contains the hub genes DCX and CRMP1, known to be
involved in cytoskeleton regulation and neuronal migration
(Gleeson et al., 1999; Goshima et al., 1995). Six additional mod-
ules are related to later phases of development, including axon
and dendrite growth and synaptogenesis (purple, salmon, green,
lightgreen, cyan, and paleturquoise). They contain hub genes
involved in glutamatergic and GABAergic synapse function
(Salmon: CAMK2b, GRIN1, GRID1, VAMP2, and SYT3/5; Green:
GRIA4, GRIK4, GRIN3A, SHANK2, RIMS1, and SV2B; Light-
green: GABRA2/5 and GABRG2/3) and genes related to axon
and dendrite growth (Table 1; Figures 5B and 5D). Consistent
with a role in synaptic function, these modules are also enriched
in genes found in biochemically isolated postsynaptic density
(PSD) fractions and in genes known to interact with PSD-95
(Baye´s et al., 2011) (Table 1; Figure S5D).
We also identified modules related to histonemodification and
chromatin remodeling (midnightblue) and RNA splicing and pro-
cessing (red, grey60, and turquoise). The midnightblue module
peaks during cortical neurogenesis and contains several mem-
bers of the chromodomain helicase family (CHD2/3) and the
MLL (MLL1/4/5) and BAF (SMARCC2 and SMARCA4) com-
plexes involved in chromatin remodeling, including BAF170/
SMARCC2, which was recently implicated in regulation of
cortical thickness (Tuoc et al., 2013). Notably, this module also
contains transcription factors associated with generation of
lower layer neurons, including BCL11B and SOX5, and is ex-
pressed early in development when these layers are formed
(Molyneaux et al., 2007). The red, grey60, and turquoisemodules
are also highly expressed early in development, but instead are
enriched in genes related to RNA processing and splicing,
including several proneural transcription factors (NEUROD1/2/
6, NEUROG2; turquoise) and transcription factors expressed in
cortical neural progenitors (FEZF2, EMX1; red) and early-gener-
ated neurons (TBR1; turquoise). Together, these modules point
to critical roles of RNA processing and epigenetic and transcrip-
tional regulation in neural stem cell differentiation during
corticogenesis.
Remarkably, we observed that 87% of genes in the network
were present in phNPC-conserved modules (17 out of 28 mod-
ules; Z score R 4) (Figure 5C; Tables 1 and S1) (Langfelder
et al., 2011), including all modules related to the major cellularNeuron 83, 69–86, July 2, 2014 ª2014 Elsevier Inc. 73
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In Vitro Stem Cells Model In Vivo Developmentand histogenetic processes discussed above. The network
architecture ofmanymodules is also strongly preserved, as visu-
ally demonstrated by in vivo and in vitro network diagrams (Fig-
ures 5D and 5E). Of the modules that were not preserved, two of
them are related to immune response (orange and black) and
neuron-microglia interactions (orange). This lack of preservation
is consistent with the composition of phNPC cultures, which
have no detectable microglia (absence of Iba1 staining, data
not shown) or immune cells. We also examined module preser-
vation at different time periods in vitro (Figures 5F–5H) and found
trends in preservation that are consistent with themodule’s func-
tion—synaptic and gliogenic modules are better preserved at
later time points (Figure 5A; Table 1). Half of the modules that
were not preserved, including two modules related to vesicle
and endosome trafficking, have eigengenes upregulated late in
development close to birth, consistent with the mid-fetal
maturity of phNPC cultures. Taken together, these parallels in
transcriptional network architecture reveal conservation of
many biochemical and cellular processes between in vivo fetal
brain and in vitro phNPC cultures.
Preserved Modules in phNPCs Are Enriched in ASD
Genes
An important question facing themodeling of neurodevelopmen-
tal diseases in vitro is to what extent disease-related processes
are conserved. Recently, we showed that ASD genes coalesce
in several transcriptionalmodules during fetal humanbrain devel-
opment (Parikshak et al., 2013). Similar to Parikshak et al. (2013),
we startedwith a curated list of ASD-associated candidate genes
(ASD SFARI) (Banerjee-Basu and Packer, 2010), which showed
strong enrichment with the highly preserved in vitro modules
related to synaptic function and neurite outgrowth (salmon and
yellow; Figure 6A). Importantly, genes coexpressed in ASD and
related to synaptic function, previously found to be downregu-
lated in the ASD brain by unbiased transcriptomic analyses
(asdM12) (Voineagu et al., 2011), were also enriched in phNPC
moduleswith overlapping function (salmon, skyblue3, lightgreen,
green, and purple modules; Figure 6A).
We next tested if rare de novo protein disrupting mutations
found in ASD (Iossifov et al., 2012; Neale et al., 2012; O’Roak
et al., 2012; Sanders et al., 2012) were similarly enriched in pre-
served modules. Similar to Parikshak et al. (2013), we found that
the conserved phNPC midnightblue module, which contains
transcriptional and chromatin regulatory genes, is enriched for
these variants (Figure 6A). Remarkably, this module and both
synaptic modules are enriched in mRNAs known to interact
with FMRP (Figure S5D), suggesting that activity-dependentFigure 3. TMAP Identifies In Vivo Developmental Period and Cortical L
Rank-rank hypergeometric overlap (RRHO) maps (Plaisier et al., 2010) comparing
developing cortex ([D] and [E]) to differentiation of phNPCs from 1–12 weeks.
(A and D) Each pixel represents the overlap between in vivo and in vitro transcripto
size = 200). On each map, the extent of shared upregulated genes is displayed in
the top right corners (see schematic on rightmost panel).
(B and E) Venn diagrams display the extent of overlap between in vivo and in vitro
and CPi (E). Gene ontology (GO Elite) analysis shows coordinately upregulated g
whereas codownregulated genes are involved in mitosis.
(C) Selected genes coordinately upregulated and coordinately downregulated arprotein translation dysregulated in ASD can be modeled
in vitro. Finally, a group of upregulated genes that is coexpressed
in ASD (asdM16; Voineagu et al., 2011) and enriched in astrocyte
and microglial markers is enriched in the preserved yellow, pink,
tan, magenta, and red modules. As microglia are not observed in
the culture, this implies that the astrocyte component of asdM16
shows enrichment in these modules.
Interestingly, genes implicated in other neurodevelopmental
diseases including intellectual disability (Inlow and Restifo,
2004; Lubs et al., 2012; Parikshak et al., 2013; Ropers, 2008;
van Bokhoven, 2011) and schizophrenia (Levinson et al., 2011)
showed enrichment with preserved modules related to basic
metabolic cellular processes (ubiquitylation, RNA splicing, and
gene expression) and synaptic transmission, respectively (Fig-
ure 6A). No enrichment was observed with genes implicated in
neurodegenerative disorders, such as late onset Alzheimer’s dis-
ease (Naj et al., 2011), though this could be due to the relatively
small number of genes identified (Figure 6A). Together, these
findings suggest that different disorders affect distinct neurode-
velopmental processes, many of which can be effectively
modeled in vitro using phNPCs.
We further assessed if the coexpression relationships of spe-
cific disease-associated genes within our in vivo defined mod-
ules were also preserved in vitro. Many ASD-associated genes
had generally similar hub status and expression pattern (Figures
6B–6E) in prenatal human cortex and in phNPCs, marking these
genes as high-priority candidates for modeling ASD in vitro.
These findings link genetic and functional evidence of ASD to
known developmental processes that can be modeled in vitro,
providing a powerful platform for therapeutic discovery.
Heterogeneity of In Vivo Modeling by Different Human
Neural Stem Cell Systems
Advances in stem cell biology in the last decade have facilitated
the use of human pluripotent cells, including hES and hiPS cells
to study development and disease (Brennand et al., 2011;
Kim et al., 2002; Marchetto et al., 2010; Millar et al., 2005; Pasxca
et al., 2011; Rosen et al., 2011; Ryan et al., 2013; Soldner et al.,
2011). However, it is still not known to what degree they recapit-
ulate in vivo development and, most importantly, which specific
processes are conserved in which system.
We evaluated the degree of overlap between developing
human cortex in vivo and these different systems using the
same functional genomics framework developed above. Data
sets of differentiating hiPSC (three data sets including one previ-
ously published [Pasxca et al., 2011] and two unpublished data
sets from two separate labs), hESC (Fathi et al., 2011), andaminae Most Similar to Differentiating phNPCs
the transitions between in vivo developmental periods ([A]–[C]) or laminae in the
me, color-coded according to thelog10 p value of a hypergeometric test (step
the bottom left corner, whereas shared downregulated genes are displayed in
transcriptomes at the best matched periods (1 versus 6; [B]) and between SZ
enes are related to synaptic transmission and nervous system development,
e graphed through time both in developing phNPCs and in vivo.
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Table 1. Summary of High-Confidence Modules Defined in Human Fetal Cortex
Module In vivo Pzscore
phNPC 
Pzscore Select Hub Genes Biological Processes Associated with Module
Magenta 17.0 40.2 BUB1, BUB1B, KIF20A Mitosis and cell cycle regulation of neural progenitors
Salmon 14.0 19.9 GRIN1, GRID1, SLC1A1, CAMK2 , VAMP2, SYT3/5 Glutamatergic synaptic transmission, axon and dendrite development
Cyan 4.1 19.4 NRXN1, PCLO, ANK2/3, MAPT, MYO5A, KIF3B/C, DOCK9 Synapse assembly and vesicle transport by actin/microtubule motors
Green 28.0 17.6 GABRB1, GRIK4, GRIN3A, SHANK2, RIMS1, SV2B, CACNA1I Glutamatergic synaptic transmission, axon and dendrite development
Lightgreen 12.0 15.9 GABRA2/5, GABRG2/3, GLRB, SNAP25, SYT1, SV2A GABAergic synaptic transmission and synaptic vesicle exocytosis
Purple 10.0 15.9 SEMA4G, SEMA6C, CRMP1, SRGAP1, DCX Axon guidance, neuronal migration and GTPase activity
Red 21.0 14.4 ACTL6A, HIST1H3H, HIST1H2BM, BUB3, CDK4, CNOT1, SRSF1 Mitosis, RNA processing and RNA splicing
Pink 15.0 7.5 HES1, NOTCH2, FGFR3, RFX4 Neural progenitor proliferation and gliogenesis
Tan 13.0 5.7 STAT6, TGFBR2/3, CXCL12, CALCRL, TGM2 Reg. of cell death, gliogenesis, immune and inflammatory processes
Skyblue3 8.8 5.5 SLC17A7, PCDH9, CNTNAP5, ARHGAP44, MGLL Neuronal, synaptic with parietal areal identity
Yellow 31.0 5.4 CAMK2A, GRIK1, GFAP, AQP4, CX3CL1 Synaptic transmission, gliogenesis and neuron microglia interaction
Midnightblue 14.0 5.1 MLL1/4/5, CHD2/3, SMARCA4, CREBBP, FOXG1 Histone modification and chromatin remodeling
Greenyellow 4.7 4.5 RBFOX1, LUC7L3, CAPRIN2 tRNA processing and RNA binding
Lightcyan 6.3 4.4 LAMA2/4, COL3A1, COL1A1/2, BMP4, SMAD6 Extracellular matrix and basement membrane, blood vessel development
Darkred 5.9 4.0 DKK1, BOK, RNF152 Programmed Cell Death
Grey60 9.8 3.7 THOC1, RBM39, PNN, MRE11A, POLA1, POLE, CNTRL RNA splicing, DNA repair and cell cyle
Darkolivegreen 4.5 2.7 COPA, COPE, COPG, VPS11, VAC14, SNAP29 Intracellular protein transport, vesicle and endosome trafficking
Paleturquoise 5.8 2.3 CACNA2D2, CHRFAM7A, SLC24A2 Synaptic transmission
Turquoise 15.0 2.3 KLHL9, CRNKL1, CREB1, HDAC2, SENP1 Ubiquitin proteolysis, RNA processing and splicing, reg. gene expression
Darkgreen 10.0 2.2 ATP6AP1, ATP6V0C, PLEKHB2, DLG4, GOT1, GBA Endosome and vesicle trafficking, synaptic
Orange 11.0 1.6 CX3CR1, TYROBP, LAPTM5, CSF1R Immune response, neuron-microglia interaction
Darkturquoise 5.0 0.7 NAPA, SORT1, AP2M1, ARF1, MAPK3 Intracellular protein transport, vesicle and endosome trafficking
Black 12.0 -0.2 BTN3A3, CFB, CTSS, DHX58, HERC5 Immune response
 ME Time
birth4 PCW
Module preservation Z scores are shown for an independent in vivo dataset of developing human cortex (Colantuoni et al., 2011) and in phNPCs.
Modules not preserved in vitro are highlighted in pink with red font, whereas modules preserved in vitro and in vivo are highlighted in green. Select
hub genes (from top 100 in each module) related to the biological processes of the module are shown. Modules with few genes (<70) lacking clear
or specific GO/KEGG enrichment and no overrepresentation of genes in manually curated lists comprising key neurodevelopmental processes, brain
cell populations, and their subcellular compartments (white, steelblue, saddlebrown, yellowgreen, and violet) are preserved in vivo but are not shown in
the table. The averagedmodule eigengene expression from 4 PCW (left) to birth (right) is plotted for eachmodule, represented as a heatmap where red
is high and blue is low relative expression.
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In Vitro Stem Cells Model In Vivo DevelopmentSY5Y neuroblastoma (Nishida et al., 2008) cells were compared
to the human cortex spatiotemporal transcriptome (Kang et al.,
2011) (Figure 7A) or the human LCM transcriptome (Miller
et al., 2014) (Figure 7B) to map the transitions between develop-
mental periods or cortical laminae in these alternate in vitro sys-
tems. These data sets from different laboratories comprise a
representative cohort of the differences in culture and differenti-
ation protocols currently available (Supplemental Experimental
Procedures). Just as with phNPCs, we found the best overlap
in all systems when comparing in vivo period 1 or 2, which
contain the germinal zones, to periods of mid-fetal development.
As expected, neuroblastoma-derived SY5Y cells had the lowest
degree of matching, while hES-derived cells matched relatively
well to in vivo cortical development (Figure 7). When differenti-
ated for the same length of time (3 weeks), phNPCs are roughly
similar to hES-derived progenitors (Figure S6B). A great degree
of heterogeneity of in vivo matching was observed in hiPSCs
cultured in different labs using different protocols. Interestingly,
hiPSC-derived progenitors from data set 1, even when differen-
tiated longer than hES-derived NPCs or phNPCs, still matchedFigure 4. CoNTExT Predicts Developmental Period and Regional Ident
(A) The CoNTExT algorithmwas trained on all samples from a spatio-temporal atla
Exon 1.0 ST Array) and validated in several postmortem expression data sets. Pro
for each sample of known regional and temporal identity (x axis).
(B) Cross platform accuracy was evaluated in 49 samples spanning all postnatal d
(Affymetrix Gene 1.0 ST Array). Developmental period was classified with 84% (±
(C) The validated machine learning algorithmwas applied to one line (donor: 8; reg
identity (Illumina HT-12 Beadchip). A clear maturation across differentiation weeks
periods of development. In addition, the cultures are predicted to be cortical, coin vivo transcriptional profiles significantly less than phNPCs
(Figures S6B and S6C). These differences were not driven by
number of samples in the data sets, as hES-derived cells (n =
6) display better matching than hiPSC-derived cells from data
set 1 (n = 29) (Supplemental Experimental Procedures). phNPCs
from 1 to 8 weeks of differentiation show significantly greater
overlap with in vivo development compared to all other in vitro
data sets except for hiPSC data set 3, which was roughly equiv-
alent to phNPCs (Figures 3A, 6B, and S6C). hiPSC data set 3
showed strong matching even at 4 weeks of differentiation,
implying that it reaches developmental maturity quicker than
phNPCs.
TMAP in laminar data (Miller et al., 2014) showed that all sys-
tems, except hiPSC data set 3, have significantly less overlap
with in vivo laminar transitions than with 8 week PD phNPCs (Fig-
ure 3D, 7B, and S6E). Overall, when differentiating for short
periods of time, laminar matching is low (Figures S3D and 7B),
suggesting that more differentiation in vitro is required to better
match in vivo development in most systems. In all systems,
more overlap was detected in transitions between proliferativeity in Individual phNPC Cultures
s of human brain expression (Kang et al., 2011) (1,340 samples using Affymetrix
bability (color in heat map) of each predicted class assignment (y axis) is shown
evelopmental periods and both cerebellar and cortical regions (Liu et al., 2012)
one period) and 100% accuracy in region.
ion: 49) of differentiating phNPCs to predict developmental period and regional
is seen at the individual sample level, with the culture reaching early to late fetal
nsistent with immunocytochemical profile and expression of regional markers.
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In Vitro Stem Cells Model In Vivo Developmentlayers (VZ and SVZ) and postmitotic layers, consistent with the
differentiation of dividing neural progenitors into post mitotic
neurons (Figures 3D and 7B).
We next applied CoNTExT to predict individual sample devel-
opmental maturity and regional identity (Figure 7C). When
CoNTExT predicted a greater difference in culture maturity
from progenitor to differentiated cells, stronger in vivo matching
was observed in TMAP. This implies that TMAP is mainly
measuring similarity to in vivo neural differentiation. This can
be seen in hiPSC data set 1where CoNTExT detected little differ-
ence in progenitor versus differentiated cultures, and TMAP
showed only a low degree of overlap. CoNTExT was also used
to predict regional identity on each individual in vitro sample.
Interestingly, several of the hiPSC cultures (data set 1 and 3)
showed mixed cortical and cerebellar regional identity. The
two samples in data set 3 classified as cortex were derived
from the same line and had greater expression of cortical
markers and lower expression of caudal markers than other
samples from the same data set (data not shown).
To assess which biological processes were preserved in these
systems, we applied the WGCNA framework. We first observed
poor preservation of network architecture in SY5Y cells. Only
the magenta module related to the cessation of proliferation
was strongly preserved (Z score > 10), while synaptic modules
were weakly preserved or not preserved, consistent with the
restricted overlap to downregulated genes in laminar transitions
in SY5Y cells (Figures 7D). Across all other in vitro systems
(phNPCs, hiPSCs, and hES-derived neural cells), a high degree
of preservation (Z > 10) was found for modules relating to neuro-
genesis and mitosis (magenta and red), neurite outgrowth and
synaptogenesis (salmon, lightgreen, and green), and RNA pro-
cessing and splicing (red). Despite these similarities, differences
in developmental processes were apparent across the hiPSC
and phNPC systems. The chromatin remodeling midnightblue
module (enriched for ASDassociateddenovo variation; Figure 6),
while preserved in phNPCs, was not preserved in the hES and
most hiPSC-derived data sets (Figure 7D; this module was pre-
served in hiPSC data set 2 when subsetting to 1 and 4 weeks
PD or 4 and 8 weeks PD; Table S1). Similarly, the pink module
related to neural progenitor proliferation and gliogenesis, and
thedarkredmodule related toprogrammedcell deathwerebetter
or uniquely preserved in phNPCs (Figure 7D). Conversely the
turquoise module was better preserved in hiPSC-derived cells.
Nonetheless, preservation scores for all highly preserved mod-
ules common to all systems were generally higher in phNPCs.Figure 5. Network Analysis Identifies Major Neurodevelopmental Proc
(A) A weighted gene coexpression network was formed using human cortex samp
cellular and histogenetic processes in the developing human brain (Andersen, 200
labeled.
(B) A subset of modules related to key neurodevelopmental processes are hig
eigengene trajectories (see Table 1 for full list).
(C) Module preservation (Langfelder et al., 2011) in phNPCs differentiated over 1
(D and E) The green module, enriched in genes involved in synaptic function, show
of the edges are weighted by the strength of bicorrelation.
(F–H) Module preservation varies over differentiation time. Early differentiatio
(midnightblue module) while later time periods ([G] and [H]) show stronger prese
lightgreen, and cyan modules) genes.DISCUSSION
Understanding how in vitro systemsmodel in vivo brain develop-
ment is becoming more important as human neural in vitro
systems are becoming more widely used. Benchmarks have
long been sought in the stem cell field (Andrews et al., 2005);
however, there currently exists no unbiased rubric on which to
base such a comparison. We reasoned that transcriptional
profiles would provide a comprehensive, unbiased foundation
on which to build such a quantitative structure at a genome-
wide level. Here, we demonstrate through multiple analytical
approaches and validate via multiple independent data sets
that phNPCs strongly match in vivo development and produce
cortical neurons reaching late mid-fetal levels of maturity after
12 weeks of differentiation. Most, but not all, neurodevelop-
mental processes of normal corticogenesis are highly preserved
in phNPCs. Risk genes for ASD, ID, and schizophrenia are en-
riched in modules related to these processes. In addition, we
find that phNPCs have a stronger overlap and matching with
in vivo cortex than other in vitro systems in common use,
including some hiPSCs. Furthermore, we identify specific neuro-
developmental processes related to ASD pathophysiology pre-
served exclusively in phNPCs and not in other in vitro models.
Overall, we provide a basic experimental framework for assess-
ing the preservation in vitro of specific biological processes and
gene networks underlying cortical development in vivo.
One expectation is that this framework will allow comprehen-
sive evaluation of in vitro systems as they are developed and
refined. A variety of protocols exist to generate hiPSCs, including
variations in the type of cells used to generate hiPSCs, the stan-
dards for characterizing resulting lines, and neural induction and
differentiation protocols (Haase et al., 2009; Obokata et al., 2014;
Takahashi et al., 2007). Going forward, the comparative frame-
work demonstrated here can be used to optimize protocols to
best model in vivo development, including 3D cultures (Kadosh-
ima et al., 2013; Lancaster et al., 2013).
All four parts of our analytic framework are complementary but
provide different information. TMAP provides a global view of
transcriptomic matching to in vivo development. TMAP is mainly
driven by differentiation processes that are not regionally spe-
cific, so it should not be considered a regional identity tool. Using
human in vivo cerebellar or striatal data as input to TMAP, for
example, still shows a high degree of in vitro matching with the
cortical phNPCs (data not shown). CoNTExT is a useful frame-
work for individual sample prediction of temporal and regionalesses that Are Preserved in Differentiating phNPCs
les from embryonic (Period 1) to neonatal periods (Period 8). Timeline of known
3; Kang et al., 2011) andmodules enriched in genes related these processes are
hlighted with corresponding GO analysis, selected hub genes, and module
2 weeks shows high preservation (ZR 4) of 12 modules.
s a similar pattern of connectivity in vivo (D) and in vitro (E). The width and color
n periods (F) show stronger preservation of chromatin modification genes
rvation of gliogenic (pink and tan modules) and synaptogenic (salmon, green,
Neuron 83, 69–86, July 2, 2014 ª2014 Elsevier Inc. 79
AB C
D E
Figure 6. phNPC Preserved Modules Are Enriched in ASD-Associated Genes
(A) In-vivo-definedmodules preserved in differentiating phNPCswere tested for enrichment of disease-associated genes from a curated list of autism-associated
genes (ASD SFARI) (Banerjee-Basu and Packer, 2010), rare de novo protein disrupting mutations found in ASD and siblings (Iossifov et al., 2012; Neale et al.,
2012; O’Roak et al., 2012; Sanders et al., 2012), two ASD-associated modules defined in postmortem brain (asdM12 and asdM16) (Voineagu et al., 2011), a
curated list of genes associated with intellectual disability (ID All) (Inlow and Restifo, 2004; Lubs et al., 2012; Parikshak et al., 2013; Ropers, 2008; van Bokhoven,
2011), the intersection of ASD SFARI with ID (ASD-ID overlap), the relative complement of these (ASD only; ID only), a list of genes disrupted by CNVs in
schizophrenia (Levinson et al., 2011), genes near significantly associated loci in GWAS of schizophrenia (Ripke et al., 2013), and genes near significantly
associated loci in GWAS of late onset Alzheimer’s disease (Naj et al., 2011). Enrichment was assessed using Fisher’s exact test, and the FDR (Benjamini and
Hochberg, 1995) correction for multiple comparisons p value is displayed.
(B) Protein disrupting de novo SNVs found in ASD are enriched in the preserved midnightblue module. The correlation of each gene to the module eigengene
(kME) is shown for in vivo and phNPC data (1 and 4week PD). ASD-associated genes are highlighted in red. Genes close to the solid red line (y = x) have the same
kME in vivo and in vitro. The dotted red line represents an in vivo kME value three times less than observed in vivo.
(C) Several genes that contain ASD-associated de novo SNVs have similar expression patterns in vivo and in vivo.
(D) kME is shown for in vivo and phNPC data (1, 4, 8, and 12 week PD) for the preserved salmon module that is enriched in asdM12 genes (Voineagu et al., 2011).
ASD-associated genes in asdM12 are in red and are labeled.
(E) Several asdM12 genes show similar expression patterns in vivo and in vitro.
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In Vitro Stem Cells Model In Vivo Developmentidentity. One caveat to its use is that the algorithmmust classify a
sample into one of the defined regions or time periods, even if it
matches none of them. As such, we defined through simulation
how the level of in vivo matching affects the accuracy of classi-
fication (Figures S4D and S4E). Finally, CoNTExT and TMAP do
not specify which molecular pathways are conserved. WGCNA
module preservation is a well-validated tool to determine the
specific functional processes that are preserved in vitro. For
those processes not conserved, modifying the expression of
key hub genes in the module using exogenous factors like small
molecules or by targeted gene expression may provide leverage
for developing more faithful in vivo modeling in the future.
The observed differences between in vitro systems could be
due to inherent properties of the system, reprogramming, culture
conditions, or even culturing technique. While with the current
data we cannot pinpoint the source of variance, it is interesting
to note that hiPSC data sets generated using more recent proto-
cols, which include addition ofmorphogens (SMAD inhibitors) for
neural induction, match better to in vivo brain. Similarly, because
the time spent in the neural induction stage differs between sys-
tems, the initial (NPC) time point may reflect different starting
points of maturity. Nonetheless, significant heterogeneity exists
evenwithin hiPSCs cultured in identical conditions. In the highest
in vivomatching hiPSCdata set byTMAP,weobservedoneclone
with strongly different regional identity compared to another
clone derived from the same donor (Figure 7; data set 3). The
in vivo transcriptomic framework provided here can be used to
systemically test how these and other factors can optimize
matching to in vivo developmental transitions or regional identify.
Differences between pluripotent-derived and primary neural
progenitors have been identified in previous studies, including
low or undetectable expression of the radial glia marker GFAP
and overall higher production of neurons upon differentiation
(Falk et al., 2012). GFAP is expressed in radial glia in vivo (Wilkin-
son et al., 1990) and in undifferentiated phNPCs, and its absence
in hiPSC-derived progenitorsmay be related to their more imma-
ture neuroepithelial nature (Falk et al., 2012).
Growing evidence implicates abnormalities in the develop-
ment and architecture of the human cerebral cortex in neuro-
psychiatric illness (Akbarian et al., 1996; Anderson et al.,
1996; Ebert and Greenberg, 2013; Gulsuner et al., 2013;
Hutsler and Zhang, 2010; Parikshak et al., 2013; Penzes
et al., 2011; Strauss et al., 2006; Wegiel et al., 2012; Willsey
et al., 2013). We identified a module related to chromatin re-
modeling (midnightblue) that is largely not preserved in hiPS-
derived neural stem cells and contains key genes involved in
the generation of lower layer neurons and that regulate cortical
thickness in rodent (Tuoc et al., 2013). Chromatin remodeling
and transcriptional regulation are key biological processes
that are enriched for protein disrupting and missense rare de
novo mutations in ASD (Parikshak et al., 2013). These findings
underscore critical differences in widely used in vitro systems
that may compromise their utility for the study of development
and neuropsychiatric disease. At the same time, because they
can be derived from well-characterized patients and carry their
full genetic background, hiPSC-derived NPCs have clear value.
Our approach provides a template to refine these systems to
better match in vivo brain development.In this regard, our analysis also highlights processes poorly
preserved in all of the vitro models, including modules related
to immune response and neuron-microglia interactions (orange
and black). A hub in the orange module, CX3CR1, is specifically
expressed in microglia and mediates neuron-microglia signaling
implicated in regulating neuronal death during neuroinflamma-
tion (Cardona et al., 2006; Fuhrmann et al., 2010). The neuronal
ligand of CX3CR1, the fractalkine CX3CL1, is in the weakly pre-
served neuronal yellow module; this signaling pair regulates
developmental synaptic pruning (Paolicelli et al., 2011). Given
the emerging role for microglia in neurodevelopmental and
neurodegenerative diseases (Paolicelli et al., 2011; Vargas
et al., 2005), it will be important to evaluate if addition ofmicroglia
to differentiating phNPCs will be sufficient to recapitulate these
processes.
These results also stress that current human neural stem cell
systems, including hiPSCs, represent an immature, fetal state,
consistent with other published work (Brennand et al., 2014; Es-
puny-Camacho et al., 2013; Kadoshima et al., 2013; Mariani
et al., 2012; Nicholas et al., 2013). This is a key issue that may
present challenges for modeling late-onset brain disorders
including Alzheimer’s disease. It will be important to evaluate
to what extent phenotypes in these immature neurons can be
translated effectively into relevant pathophysiological insights
(Sandoe and Eggan, 2013). Transcriptomic data can be lever-
aged to identify key processes and genes that may drive the
generation of specific populations of cells or a desired level of
maturity.
The methods presented here represent a first step in deter-
mining the degree of matching of in vitro systems to in vivo
development. We realize that the ultimate understanding of
how well in vitro cultures match in vivo development will be
from matching individual cell transcriptomes from different re-
gions, laminae, and developmental time periods to individual
cell transcriptomes grown in culture. Importantly, in the future
as comprehensive data sets of additional genomic data across
cell populations in the developing brain become available, our
approach can integrate different data modalities to provide a
robust picture of the matching of neural stem cell models to
in vivo brain. This approach can also provide mechanistic
insight into differences between systems, which can be lever-
aged to improve the fidelity of in vitro models. This is especially
important if our goal is to understand and develop treatments
for human disease.EXPERIMENTAL PROCEDURES
Tissue Acquisition and Cell Culture
Human fetal brain tissue was obtained from the UCLA Gene and Cell Therapy
Core following IRB regulations. phNPC cultures were prepared from PCW
15–18 human fetal brain as described (Konopka et al., 2012; Wexler et al.,
2011) and detailed in Supplemental Experimental Procedures.Genotyping
DNAwas acquired from phNPCs cultures or fetal brain tissue and donors were
genotyped with Illumina HumanOmni2.5 chips. Sex was determined based on
homozygosity in X chromosome SNPs (two male; one female). High confi-
dence CNVs called with CNVision (Sanders et al., 2011) were not found in
autism-associated regions.Neuron 83, 69–86, July 2, 2014 ª2014 Elsevier Inc. 81
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Figure 7. The Extent of In Vivo Overlap Observed in Multiple In Vitro Neural Stem Cell Models
(A and B) The transitions between in vivo developmental periods of neocortex (Kang et al., 2011) (A) or laminae in the developing cortex (Miller et al., 2014) (B) are
compared to the transition between proliferative and differentiated neuronal cultures derived from thre data sets of hiPSC cells, hES (Fathi et al., 2011), and SY5Y
(legend continued on next page)
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Immunostaining was performed on PFA fixed cells with the indicated anti-
bodies and the DNA-binding dye 40,6-diamidino-2-phenylindole (DAPI) to
quantify total cell number and cell viability. Detailed protocol and a list of
antibodies used in this study is provided in Supplemental Experimental Proce-
dures. Images were captured using a Zeiss Axio Imager D1 (Thornwood)
epifluorescence microscope and analyzed using ImageJ software.RNA Isolation, Processing, and Microarray Hybridization
For each of 5 lines generated from three donors (15–16 PCW), two indepen-
dent differentiation experiments each containing two replicates were
performed and harvested at four time points (1, 4, 8, and 12 weeks PD; 16
samples per line; 77 total samples). RNA was isolated using TRIzol reagent
(Invitrogen) according to standard protocols. We confirmed RNA integrity by
RIN score with the Agilent 2100 Bioanalyzer (mean ± SD: 9.16 ± 0.78). Further
details are found in Supplemental Experimental Procedures. All RNA expres-
sion profiles acquired as part of this project are publicly available (GSE57595).TMAP
A spatiotemporal atlas of human brain gene expression (Kang et al., 2011) and
laminar expression data dissected via Laser Capture Microdissection from
fetal human brain (Miller et al., 2014) were downloaded. For TMAP, differential
expression between time points was calculated using a mixed effects model
implemented in the nlme package (Pinheiro and Bates, 2009), with a random
effect representing cell line (in vitro) or donor (in vivo), to appropriately account
for the repeated-measures of multiple nonindependent samples (replicates of
lines in phNPCs; multiple regions from the same donor in vivo). The rank-rank
hypergeometric overlap test (Plaisier et al., 2010) was implemented using
custom R scripts now available as a Bioconductor package (RRHO) to eval-
uate overlap between in vivo and in vitro data sets. Further details are found
in Supplemental Experimental Procedures.CoNTExT
A multiclass, multilabel machine learning algorithm was implemented in the
MEKA toolbox (http://meka.sourceforge.net/) (Read, 2010) and trained on all
1,340 samples of the Kang et al., 2011 data using all regions and all time points.
Classification accuracy of developmental period was evaluated for each
downloaded data set within a range of ±1 from the true value to account for
edge effects and ambiguities in the determination of conception date. For
each sample, the probability of belonging to each class was output and dis-
played in Figures 4 and S4. A simulation was conducted to judge the accuracy
of the classifier at different levels on in vivo matching Figure S4. Further details
are found in Supplemental Experimental Procedures.WGCNA
WGCNA was conducted using the R package WGCNA (Langfelder and
Horvath, 2008) on the neocortical samples from Kang et al. (2011) data set
from time periods 1 through 8. Module preservation analysis was conducted
to determine if density and connectivity-based measures were preserved
in vitro (Langfelder et al., 2011). Further details are found in Supplemental
Experimental Procedures.GO Ontologies
GO analysis was completed using GO-Elite v1.2.5 with default settings
(Zambon et al., 2012). Relevant biological process and molecular function
categories were plotted selected from the top 10 terms ranked by Z score.neuroblastoma (Nishida et al., 2008) cells. The color bars are on the same scale as
Figure S6.
(C) Themachine learning framework CoNTExT was used to predict the regional an
differentiated is labeled below the heatmaps. The accuracy of CoNTExT prediction
have accurate predictions (Figure S4).
(D) Module preservation was used to test which processes were conserved in diSUPPLEMENTAL INFORMATION
Supplemental Information includes six figures, one table, and Supplemental
Experimental Procedures and can be found with this article online at http://
dx.doi.org/10.1016/j.neuron.2014.05.035.
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